Sponsored
Jeplus.in
Purchase All Medicines.Get 10% Offer
Pharma Tech
AHA26: Semaglutide’s real-world CV benefits highlight importance of persistence
Real-world semaglutide CV outcomes mirror clinical trials, with greater treatment persistence linked to better outcomes.
Read Full Article
Pharma Tech
BIO Europe: Financing, AI and geopolitics shape biotech discourseÂ
Speakers at BIO-Europe 2026 noted that European biotechs must be agile and adaptable in times of geopolitical and financial upheaval.
Read Full Article
PharmaShots
Top 20 Cardiometabolic Prescription Drugs of 2026
Shots: 20. Xultophy Non-Proprietary Name: Insulin degludec/liraglutide Company: Novo Nordisk First Approved: EU (2014), US (2016) FY2025 Revenue: $0.72B FY2024 Revenue: $0.62B YoY Growth: +15.7% 19. Kerendia Non-Proprietary Name: Finerenone Company: Bayer First Approved: US (2021), EU (2022) FY2025 Revenue: $0.97B FY2024 Revenue: $0.48B YoY Growth: +102% 18. Leqvio Non-Proprietary Name: Inclisiran Company: Novartis First Approved: US (2021), EU (2020) FY2025 Revenue: $1.19B FY2024 Revenue: $0.75B YoY Growth: +58.9% 17.… The post Top 20 Cardiometabolic Prescription Drugs of 2026 appeared first on PharmaShots.
Read Full Article
Pharma Tech
FDA puts commissioner’s priority voucher framework on ice Â
Experts consistently questioned how vouchers were awarded, along with critiquing its wider industry benefits.
Read Full Article
Express Pharma
From volume to value: How India’s pharma industry can move up the global value chain
Arun Patel, Founder and Partner, Arunasset Investment Services, explains how India’s pharma industry can move beyond volume-led growth and strengthen its position in the global value chain The post From volume to value: How India’s pharma industry can move up the global value chain appeared first on Express Pharma.
Read Full Article
Sponsored content
Featured promotional
News
Latest stories
Pharma Tech
Nov 13, 2026, 4:07 PM
AHA26: Semaglutide’s real-world CV benefits highlight importance of persistence
Real-world semaglutide CV outcomes mirror clinical trials, with greater treatment persistence linked to better outcomes.
Pharma Tech
Nov 13, 2026, 3:36 PM
BIO Europe: Financing, AI and geopolitics shape biotech discourseÂ
Speakers at BIO-Europe 2026 noted that European biotechs must be agile and adaptable in times of geopolitical and financial upheaval.
PharmaShots
Nov 13, 2026, 1:30 PM
Top 20 Cardiometabolic Prescription Drugs of 2026
Shots: 20. Xultophy Non-Proprietary Name: Insulin degludec/liraglutide Company: Novo Nordisk First Approved: EU (2014), US (2016) FY2025 Revenue: $0.72B FY2024 Revenue: $0.62B YoY Growth: +15.7% 19. Kerendia Non-Proprietary Name: Finerenone Company: Bayer First Approved: US (2021), EU (2022) FY2025 Revenue: $0.97B FY2024 Revenue: $0.48B YoY Growth: +102% 18. Leqvio Non-Proprietary Name: Inclisiran Company: Novartis First Approved: US (2021), EU (2020) FY2025 Revenue: $1.19B FY2024 Revenue: $0.75B YoY Growth: +58.9% 17.… The post Top 20 Cardiometabolic Prescription Drugs of 2026 appeared first on PharmaShots.
Pharma Tech
Nov 13, 2026, 11:40 AM
FDA puts commissioner’s priority voucher framework on ice Â
Experts consistently questioned how vouchers were awarded, along with critiquing its wider industry benefits.
Express Pharma
Nov 13, 2026, 11:32 AM
From volume to value: How India’s pharma industry can move up the global value chain
Arun Patel, Founder and Partner, Arunasset Investment Services, explains how India’s pharma industry can move beyond volume-led growth and strengthen its position in the global value chain The post From volume to value: How India’s pharma industry can move up the global value chain appeared first on Express Pharma.
Pharma Tech
Nov 13, 2026, 11:28 AM
Neurosterix pockets $105m to advance neuropsychiatry pipelineÂ
Neurosterix hopes that NTX-253 may compete with BMS’s Cobenfy as the schizophrenia field explores mechanisms past dopamine modulation.
News
Latest industry coverage
Google News
Nov 13, 2026, 11:40 PM
Teva Pharmaceutical Industries Limited (TEVA) R&D Day: Pivot to Growth Strategy, Pipeline and Financial Outlook - Slideshow - Seeking Alpha
Teva Pharmaceutical Industries Limited (TEVA) R&D Day: Pivot to Growth Strategy, Pipeline and Financial Outlook - Slideshow  Seeking Alpha
Google News
Nov 13, 2026, 10:45 PM
AstraZeneca cuts 600 US sales jobs amid $1.5B savings plan: Bloomberg - Fierce Pharma
AstraZeneca cuts 600 US sales jobs amid $1.5B savings plan: Bloomberg  Fierce Pharma
Google News
Nov 13, 2026, 10:42 PM
Amgen vs. Vertex Pharmaceuticals: Which Healthcare Stock Is a Better Buy for 2027? - The Motley Fool
Amgen vs. Vertex Pharmaceuticals: Which Healthcare Stock Is a Better Buy for 2027?  The Motley Fool
Google News
Nov 13, 2026, 10:40 PM
Pharmaceutical ads may influence which drug AI recommends, new research finds - Fast Company
Pharmaceutical ads may influence which drug AI recommends, new research finds  Fast Company
Google News
Nov 13, 2026, 10:18 PM
CGT Catapult chief Matthew Durdy to retire in 2027 after 15 years - The Pharma Letter
CGT Catapult chief Matthew Durdy to retire in 2027 after 15 years  The Pharma Letter
Google News
Nov 13, 2026, 9:34 PM
Oncolytics, Coherus to Partner on Clinical Study in SCAC Patients - Contract Pharma
Oncolytics, Coherus to Partner on Clinical Study in SCAC Patients  Contract Pharma
Google News
Nov 13, 2026, 9:04 PM
Sino Biological Rolls Out High-Throughput Wet Lab Validation Services for AI-Designed Protein Binders - Contract Pharma
Sino Biological Rolls Out High-Throughput Wet Lab Validation Services for AI-Designed Protein Binders  Contract Pharma
Google News
Nov 13, 2026, 8:56 PM
Novo Nordisk Wins EU Approval for FREHEMGO in Hemophilia A - Contract Pharma
Novo Nordisk Wins EU Approval for FREHEMGO in Hemophilia AÂ Â Contract Pharma
Google News
Nov 13, 2026, 8:52 PM
Texas Life Science Forum draws more than 600 industry leaders, entrepreneurs and investors to Rice - Rice University
Texas Life Science Forum draws more than 600 industry leaders, entrepreneurs and investors to Rice  Rice University
Sponsored placement
Featured promotions
Sponsored
Jeplus.in
Purchase All Medicines.Get 10% Offer